Pakistan State Oil (PSO), the country’s national energy company, announced its financial results for the nine months ended ...

KARACHI: Pakistan State Oil (PSO), the nation’s energy company, has announced its financial results for the nine months of ...

Defense Secretary Pete Hegseth and Gen. Dan Caine, chairman of the Joint Chiefs of Staff, are testifying before the House ...

Pearson (PSO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Bimekizumab is associated with significant improvements through 3 years across various patient-reported outcomes in those with plaque psoriasis.

The Environment and Sustainable Development 5 Minute Fix is your quick update on key ESD developments across Australia. This edition covers the updates to the Commonwealth's National Greenhouse and ...

A major structural shift is happening in Pakistan’s petroleum sector as legacy Western companies exit, quickly replaced by ...

Alumis is preparing to file its oral TYK2 inhibitor envudeucitinib as a treatment for psoriasis later this year, after a pair of positive phase 3 trials. The South San Francisco biotech said ...

EverGen Infrastructure Corp. ("EverGen" or the "Company") (TSXV: EVGN) (OTCQB: EVGIF), reported audited financial results as ...

The benchmark KSE-100 index swung between the intra-day high of 169,686 and low of 165,391, reflecting heightened volatility.

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

At the recent American Academy of Dermatology (AAD) annual meeting, new phase III data from the LATITUDE-PsO-3001 and ...